Egon A. Ozer

5.1k total citations
104 papers, 2.5k citations indexed

About

Egon A. Ozer is a scholar working on Infectious Diseases, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Egon A. Ozer has authored 104 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 30 papers in Molecular Biology and 29 papers in Molecular Medicine. Recurrent topics in Egon A. Ozer's work include Antibiotic Resistance in Bacteria (29 papers), SARS-CoV-2 and COVID-19 Research (22 papers) and Bacterial biofilms and quorum sensing (17 papers). Egon A. Ozer is often cited by papers focused on Antibiotic Resistance in Bacteria (29 papers), SARS-CoV-2 and COVID-19 Research (22 papers) and Bacterial biofilms and quorum sensing (17 papers). Egon A. Ozer collaborates with scholars based in United States, Türkiye and Peru. Egon A. Ozer's co-authors include Alan R. Hauser, Joseph Zabner, Vanderlene L. Kung, E. Peter Greenberg, Jonathan P. Allen, Mark J. Mandel, Michael J. Welsh, Margaret A. Fitzpatrick, Aldons J. Lusis and Diana M. Shih and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Egon A. Ozer

96 papers receiving 2.5k citations

Peers

Countries citing papers authored by Egon A. Ozer

Since Specialization

Citations

This map shows the geographic impact of Egon A. Ozer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Egon A. Ozer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Egon A. Ozer more than expected).

Fields of papers citing papers by Egon A. Ozer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Egon A. Ozer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Egon A. Ozer. The network helps show where Egon A. Ozer may publish in the future.

Co-authorship network of co-authors of Egon A. Ozer

This figure shows the co-authorship network connecting the top 25 collaborators of Egon A. Ozer. A scholar is included among the top collaborators of Egon A. Ozer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Egon A. Ozer. Egon A. Ozer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Linezolid-resistant Enterococcus faecium clinical isolates from Pakistan: a genomic analysis 2024 ·BMC Microbiology ·(unknown), (unknown), Najia Karim Ghanchi, (unknown), (unknown), (unknown), Javaria Ashraf, Kauser Jabeen, Joveria Farooqi, Zahra Hasan, (unknown), (unknown), Syed Faisal Mahmood, Mehreen Arshad, Erum Khan, Egon A. Ozer, Rumina Hasan	2
2	Evolution of SARS-CoV-2 in the murine central nervous system drives viral diversification 2024 ·Nature Microbiology ·(unknown), Lacy M. Simons, Ramón Lorenzo-Redondo, (unknown), Laura Cooper, Tanushree Dangi, Pablo Penaloza‐MacMaster, Egon A. Ozer, Sarah E. Lutz, Lijun Rong, Judd F. Hultquist, Justin M. Richner	4
3	Surveillance Metrics and History of the COVID-19 Pandemic in Central Asia: Updated Epidemiological Assessment 2024 ·JMIR Public Health and Surveillance ·(unknown), Egon A. Ozer, (unknown), (unknown), Sarah B Welch, Yingxuan Liu, (unknown), Robert L. Murphy, Claudia Hawkins, Maryann Mason, Chad J. Achenbach, Lori Ann Post	0
4	Updated Surveillance Metrics and History of the COVID-19 Pandemic (2020-2023) in Sub-Saharan Africa: Longitudinal Trend Analysis 2024 ·JMIR Public Health and Surveillance ·(unknown), (unknown), (unknown), Egon A. Ozer, Sarah B Welch, Maryann Mason, Robert L. Murphy, Claudia Hawkins, Yingxuan Liu, Charles B. Moss, (unknown), Chad J. Achenbach, Lori Ann Post	1
5	Individual meropenem epithelial lining fluid and plasma PK/PD target attainment 2023 ·Antimicrobial Agents and Chemotherapy ·(unknown), Paul R. Yarnold, Marc H. Scheetz, Michael Neely, Mengjia Kang, Helen K. Donnelly, (unknown), (unknown), (unknown), Alan R. Hauser, Egon A. Ozer, (unknown), Alexander V. Misharin, Richard G. Wunderink, Nathaniel J. Rhodes	2
6	Severity of Illness Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in Children: A Single-Center Retrospective Cohort Study 2022 ·Journal of the Pediatric Infectious Diseases Society ·(unknown), Ramón Lorenzo-Redondo, (unknown), Lacy M. Simons, Judd F. Hultquist, Ami B. Patel, Egon A. Ozer, William J. Muller, Taylor Heald‐Sargent, Matthew D. McHugh, (unknown), (unknown), (unknown), (unknown), Larry K. Kociolek	13
7	Assessment of Virological Contributions to COVID-19 Outcomes in a Longitudinal Cohort of Hospitalized Adults 2022 ·Open Forum Infectious Diseases ·Lacy M. Simons, Ramón Lorenzo-Redondo, (unknown), (unknown), (unknown), Nina L. Reiser, Mesut Eren, (unknown), Elizabeth M. McNally, Anat R. Tambur, Douglas E. Vaughan, (unknown), Alexis R. Demonbreun, K.J.F. Satchell, Chad J. Achenbach, Egon A. Ozer, Michael G. Ison, Judd F. Hultquist	9
8	Functional and Structural Characterization of OXA-935, a Novel OXA-10-Family β-Lactamase from Pseudomonas aeruginosa 2022 ·Antimicrobial Agents and Chemotherapy ·Nathan B. Pincus, Mónica Rosas‐Lemus, Samuel W. M. Gatesy, (unknown), J.S. Brunzelle, G. Minasov, L. Shuvalova, (unknown), K.J.F. Satchell, Egon A. Ozer, Alan R. Hauser, (unknown)	9
9	Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data Estimates 2022 ·JMIR Public Health and Surveillance ·(unknown), Ramón Lorenzo-Redondo, Judd F. Hultquist, Claudia Hawkins, Egon A. Ozer, Sarah B Welch, P. V. Vara Prasad, Chad J. Achenbach, Janine White, James F. Oehmke, Robert L. Murphy, (unknown), Lori Ann Post	3
10	Placental Pathology After SARS-CoV-2 Infection in the Pre-Variant of Concern, Alpha / Gamma, Delta, or Omicron Eras 2022 ·International Journal of Surgical Pathology ·Elisheva D. Shanes, Emily S. Miller, Sebastián Otero, (unknown), (unknown), (unknown), Egon A. Ozer, Leena B. Mithal, Jeffrey A. Goldstein	28
11	Has Omicron Changed the Evolution of the Pandemic? 2022 ·JMIR Public Health and Surveillance ·(unknown), Ramón Lorenzo-Redondo, Egon A. Ozer, Claudia Hawkins, Judd F. Hultquist, Sarah B Welch, P. V. Vara Prasad, James F. Oehmke, Chad J. Achenbach, Robert L. Murphy, Janine White, (unknown), Lori Ann Post	30
12	Screening Students and Staff for Asymptomatic Coronavirus Disease 2019 in Chicago Schools 2021 ·The Journal of Pediatrics ·(unknown), (unknown), (unknown), Judd F. Hultquist, William J. Muller, Egon A. Ozer, Ramón Lorenzo-Redondo, Patrick C. Seed, Lacy M. Simons, Karen Sheehan, (unknown), Larry K. Kociolek	3
13	Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae 2021 ·Antimicrobial Agents and Chemotherapy ·Yanqin Huang, (unknown), (unknown), Nidhi Singh, Jiping Wang, Ke Chen, Yinzhi Lang, Jieqiang Zhou, (unknown), Fiorella Krapp, Egon A. Ozer, Alan R. Hauser, Jian Li, Jürgen B. Bulitta, Zackery P. Bulman	17
14	Genomic Features Associated with the Degree of Phenotypic Resistance to Carbapenems in Carbapenem-Resistant Klebsiella pneumoniae 2021 ·mSystems ·Zackery P. Bulman, Fiorella Krapp, Nathan B. Pincus, Eric Wenzler, Katherine R. Murphy, Chao Qi, Egon A. Ozer, Alan R. Hauser	32
15	Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae 2021 ·Journal of Antimicrobial Chemotherapy ·Yanqin Huang, (unknown), Eric Wenzler, Egon A. Ozer, Fiorella Krapp, Jürgen B. Bulitta, Alan R. Hauser, Zackery P. Bulman	19
16	A Genome-Based Model to Predict the Virulence of Pseudomonas aeruginosa Isolates 2020 ·mBio ·Nathan B. Pincus, Egon A. Ozer, Jonathan P. Allen, Marcus Nguyen, James J. Davis, Deborah R. Winter, (unknown), Cheng‐Hsun Chiu, Laura Zamorano, Antonio Oliver, Alan R. Hauser	18
17	Discovery of a New Neisseria gonorrhoeae Type IV Pilus Assembly Factor, TfpC 2020 ·mBio ·Linda I. Hu, Shaohui Yin, Egon A. Ozer, (unknown), Saima Rehman, James A. Garnett, H. Steven Seifert	8
18	Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6’)-Ib 2020 ·Journal of Antimicrobial Chemotherapy ·David A. Butler, (unknown), Fiorella Krapp, Shitalben Patel, Yanqin Huang, Egon A. Ozer, Alan R. Hauser, Zackery P. Bulman	13
19	Draft Genome Sequence of a Multidrug-Resistant Klebsiella quasipneumoniae subsp. similipneumoniae Isolate from a Clinical Source 2016 ·Genome Announcements ·Egon A. Ozer, Andrew R. Morris, Fiorella Krapp, Christopher S. Henry, Keith E. J. Tyo, Wyndham W. Lathem, Alan R. Hauser	4
20	Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human airway epithelia 2004 ·Proceedings of the National Academy of Sciences ·(unknown), Egon A. Ozer, Michael J. Welsh, Joseph Zabner, E. Peter Greenberg	219

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact